Pocket Guide to Radiation Oncology-2판

Part I: Central Nervous System Neoplasms
1: Brain Metastasis
2: Glioblastoma Multiforme and High-Grade Glioma
3: Low Grade Glioma
4: Meningioma
5: Vestibular Schwannoma
6: Pituitary Tumors
Central Nervous System Treatment Planning Dose Constraints

Part II: Head and Neck Cancers
7: Nasopharynx Cancer
8: Nasal Cavity and Paranasal Sinus
9: Oropharynx Cancer
10: Oral Cavity and Lip Cancers
11: Major Salivary Gland Tumors
12: Larynx and Hypopharynx Cancers
13: Thyroid Cancer
14: Occult Primary Cancer of the Head and Neck
Head and Neck Treatment Planning Dose Constraints

Part III: Thoracic Cancers
15: Non-Small Cell Lung Cancer
16: Small Cell Lung Cancer
17: Mesothelioma
18: Thymoma and Thymic Carcinoma
Thoracic Treatment Planning Dose Constraints

Part IV: Breast Cancer
19: Breast Cancer
Breast Treatment Planning Dose Constraints

Part V: Gastrointestinal Cancers
20: Esophageal Cancer
21: Gastric Cancer
22: Hepatobiliary Cancer
23: Pancreatic Cancer
24: Rectal Cancer
25: Anal Cancer
Gastrointestinal Treatment Planning Dose Constraints

Part VI: Gynecologic Cancers
26: Ovarian Cancer
27: Endometrial Cancer
28: Cervical Cancer
29: Vaginal Cancer
30: Vulvar Cancer
Gynecologic Treatment Planning Dose Constraints

Part VII: Genitourinary Cancers
31: Prostate Intact
32: Adjuvant/Salvage Prostate Cancer Treatment
33: Bladder Cancer
34: Seminoma
34: Seminoma

Part VIII: Lymphoma
35: Hodgkin Lymphoma
36: Non-Hodgkin Lymphoma
37: Multiple Myeloma and Plasmacytoma
38: Cutaneous Lymphoma
Lymphoma Treatment Planning Dose Constraints

Part IX: Sarcoma
39: Soft Tissue Sarcoma
Sarcoma Treatment Planning Dose Constraints

Part X: Skin Cancers
40: Cutaneous Squamous Cell and Basal Cell Carcinomas
41: Malignant Melanoma
42: Merkel Cell Carcinoma

Part XI: Pediatric Malignancies
43: Ependymoma
44: Medulloblastoma
45: Neuroblastoma
46: Wilms’ Tumor
47: Rhabdomyosarcoma
48: Ewing’s Sarcoma
49: Pediatric Leukemia

Part XII: Metastatic Disease
50: Oligometastatic Disease
51: Palliative Radiation

Part XIII: Benign Indications
52: Benign Fibromatoses
53: Keloids
54: Heterotopic Ossification

Part XIV: Techniques
55: Proton Radiation Therapy
Appendix 1:. Common Medications in Radiation Oncology
Appendix 2:. Normal Tissue Tolerances
Appendix 3:. Radiation and Targeted or Immunotherapeutic Agents